Gaps in COPD Guidelines of Low- and Middle-Income Countries

Abstract

Background Guidelines are critical for facilitating cost-effective COPD care. Development and implementation in low-and middle-income countries (LMICs) is challenging. To guide future strategy, an overview of current global COPD guidelines is required. Research Question We systematically reviewed national COPD guidelines, focusing on worldwide availability and identification of potential development, content, context, and quality gaps that may hamper effective implementation. Study Design and Methods Scoping review of national COPD management guidelines. We assessed: (1) global guideline coverage; (2) guideline information (authors, target audience, dissemination plans); (3) content (prevention, diagnosis, treatments); (4) ethical, legal, and socio-economic aspects; and (5) compliance with the eight Institute of Medicine (IOM) guideline standards. LMICs guidelines were compared with those from high-income countries (HICs). Results Of the 61 national COPD guidelines identified, 30 were from LMICs. Guidelines did not cover 1.93 billion (30.2%) people living in LMICs, whereas only 0.02 billion (1.9%) in HICs were without national guidelines. Compared with HICs, LMIC guidelines targeted fewer health-care professional groups and less often addressed case finding and co-morbidities. More than 90% of all guidelines included smoking cessation advice. Air pollution reduction strategies were less frequently mentioned in both LMICs (47%) and HICs (42%). LMIC guidelines fulfilled on average 3.37 (42%) of IOM standards, compared with 5.29 (66%) in HICs ( P < .05). LMICs scored significantly lower compared with HICs regarding conflicts of interest management, updates, articulation of recommendations, and funding transparency (all, P < .05). Interpretation Several development, content, context, and quality gaps exist in COPD guidelines from LMICs that may hamper effective implementation. Overall, COPD guidelines in LMICs should be more widely available and should be transparently developed and updated. Guidelines may be further enhanced by better inclusion of local risk factors, case findings, and co-morbidity management, preferably tailored to available financial and staff resources.

Enhanced recovery after surgery (ERAS®) protocol adapted to the Brazilian reality: a prospective cohort study for thoracic patients

“…According to the United Nations (40), the global population could reach 8.5 billion people in 2030, demonstrating the importance to provide excellent care, control public and private expenditure burden and reestablishing patients' and caregivers' social responsibilities. Likewise, collaboration between LMICs and high-income countries can assist in optimizing knowledge for guidelines implementation (14,15). In our experience, PROSM can assist hospitals to improve their process and achieve a future ERAS Certification.…”

“…Nonetheless designing and implementing protocols can be a challenge. The scenario in Low-Middle income countries (LMICs) demands tailored protocols that are capable of associating local comorbidities, infrastructure, professionals and other resource availability (14,15). Specifically, in Latin America, a pioneering multimodal program was initiated in Brazilian territory by 2005 (16).…”

Economic evaluations of chronic obstructive pulmonary disease pharmacotherapy: how well are the real-world issues of medication adherence, comorbidities and adverse drug-reactions addressed?

“…One final observation deserves a comment. Thus far, health economic evidence for COPD pharmacotherapy comes almost exclusively from high-income countries, while the studied realworld issues stretch way beyond these countries and may be of even more importance in low -and middle income countries (LMIC) [66]. Further efforts should be made to fill these real-world economic evidence gaps also in LMIC settings.…”

Challenges in the Implementation of Chronic Obstructive Pulmonary Disease Guidelines in Low- and Middle-Income Countries: An Official American Thoracic Society Workshop Report

“…Figure1. Global national chronic obstructive pulmonary disease guideline coverage(22). Red colors represent low-and middle-income countries, and blue colors represent high-income countries.…”